申请人:Incyte Corporation
公开号:US20140045814A1
公开(公告)日:2014-02-13
The present invention relates to pyrazine derivatives, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
本发明涉及吡啶衍生物和包括其在内的药物组合物,它们是一种或多种FGFR酶的抑制剂,并且在治疗FGFR相关疾病如癌症方面是有用的。